MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/neuonc/noab219

Медицинская библиотека · Neuro-oncology · 2022

Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas.

Ijare Omkar B, Hambarde Shashank, Brasil da Costa Fabio Henrique, Lopez Sophie, Sharpe Martyn A, Helekar Santosh A, Hangel Gilbert, Bogner Wolfgang, Widhalm Georg, Bachoo Robert M, Baskin David S, Pichumani Kumar

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

We postulate that meningiomas undergo distinct metabolic reprogramming in tumorigenesis and unraveling their metabolic phenotypes provide new therapeutic insights. Glutamine catabolism is key to the growth and proliferation of tumors. Here, we investigated the metabolomics of freshly resected meningiomas and glutamine metabolism in patient-derived meningioma cells.

METHODS

1H NMR spectroscopy of tumor tissues from meningioma patients was used to differentiate the metabolite profiles of grade-I and grade-II meningiomas. Glutamine metabolism was examined using 13C/15N glutamine tracer, in 5 patient-derived meningioma cells.

RESULTS

Alanine, lactate, glutamate, glutamine, and glycine were predominantly elevated only in grade-II meningiomas by 74%, 76%, 35%, 75%, and 33%, respectively, with alanine and glutamine levels being statistically significant (P ≤ .02). 13C/15N glutamine tracer experiments revealed that both grade-I and -II meningiomas actively metabolize glutamine to generate various key carbon intermediates including alanine and proline that are necessary for the tumor growth. Also, it is shown that glutaminase (GLS1) inhibitor, CB-839 is highly effective in downregulating glutamine metabolism and decreasing proliferation in meningioma cells.

CONCLUSION

Alanine and glutamine/glutamate are mainly elevated in grade-II meningiomas. Grade-I meningiomas possess relatively higher glutamine metabolism providing carbon/nitrogen for the biosynthesis of key nonessential amino acids. GLS1 inhibitor (CB-839) is very effective in downregulating glutamine metabolic pathways in grade-I meningiomas leading to decreased cellular proliferation.

Для цитирования: Ijare Omkar B, Hambarde Shashank, Brasil da Costa Fabio Henrique, Lopez Sophie, Sharpe Martyn A, Helekar Santosh A, Hangel Gilbert, Bogner Wolfgang, Widhalm Georg, Bachoo Robert M, Baskin David S, Pichumani Kumar. Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas.. Neuro-oncology. 2022. DOI: 10.1093/neuonc/noab219.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.